Shih JY - Search Results

1

RELAY Subgroup Analyses by EGFR Ex19del and Ex21L858R Mutations for Ramucirumab Plus Erlotinib in Metastatic Non-Small Cell Lung Cancer.

Nakagawa K, Nadal E, Garon EB, Nishio M, Seto T, Yamamoto N, Park K, Shih JY, Paz-Ares L, Frimodt-Moller B, Zimmermann AH, Wijayawardana S, Visseren-Grul C, Reck M. Nakagawa K, et al. Among authors: shih jy. Clin Cancer Res. 2021 Oct 1;27(19):5258-5271. doi: 10.1158/1078-0432.CCR-21-0273. Clin Cancer Res. 2021. PMID: 34301751 Free PMC article. Clinical Trial.

2

Tumor-associated antigen L6 and the invasion of human lung cancer cells.

Kao YR, Shih JY, Wen WC, Ko YP, Chen BM, Chan YL, Chu YW, Yang PC, Wu CW, Roffler SR. Kao YR, et al. Among authors: shih jy. Clin Cancer Res. 2003 Jul;9(7):2807-16. Clin Cancer Res. 2003. PMID: 12855661

3

Cyclooxygenase-2 induces EP1- and HER-2/Neu-dependent vascular endothelial growth factor-C up-regulation: a novel mechanism of lymphangiogenesis in lung adenocarcinoma.

Su JL, Shih JY, Yen ML, Jeng YM, Chang CC, Hsieh CY, Wei LH, Yang PC, Kuo ML. Su JL, et al. Among authors: shih jy. Cancer Res. 2004 Jan 15;64(2):554-64. doi: 10.1158/0008-5472.can-03-1301. Cancer Res. 2004. PMID: 14744769

4

Cardiac involvement in malignancies. Case 1. Favorable outcome of a patient with cardiac invasion from non-small-cell lung carcinoma.

Tsai MS, Ko PC, Shih JY, Chang YL, Chen SC, Chiang WC, Chen WJ. Tsai MS, et al. Among authors: shih jy. J Clin Oncol. 2004 Jul 1;22(13):2740-2. doi: 10.1200/JCO.2004.08.104. J Clin Oncol. 2004. PMID: 15226342 No abstract available.

5

Prognosis of non-small cell lung cancer patients by detecting circulating cancer cells in the peripheral blood with multiple marker genes.

Sher YP, Shih JY, Yang PC, Roffler SR, Chu YW, Wu CW, Yu CL, Peck K. Sher YP, et al. Among authors: shih jy. Clin Cancer Res. 2005 Jan 1;11(1):173-9. Clin Cancer Res. 2005. PMID: 15671543

6

Epidermal growth factor receptor mutations in needle biopsy/aspiration samples predict response to gefitinib therapy and survival of patients with advanced nonsmall cell lung cancer.

Shih JY, Gow CH, Yu CJ, Yang CH, Chang YL, Tsai MF, Hsu YC, Chen KY, Su WP, Yang PC. Shih JY, et al. Int J Cancer. 2006 Feb 15;118(4):963-9. doi: 10.1002/ijc.21458. Int J Cancer. 2006. PMID: 16152581

7

Gefitinib treatment for non-small cell lung cancer -- a study including patients with poor performance status.

Su WP, Yang CH, Yu CJ, Shih JY, Hsu C, Yang PC. Su WP, et al. Among authors: shih jy. J Formos Med Assoc. 2005 Aug;104(8):557-62. J Formos Med Assoc. 2005. PMID: 16193176

8

Transcription repressor slug promotes carcinoma invasion and predicts outcome of patients with lung adenocarcinoma.

Shih JY, Tsai MF, Chang TH, Chang YL, Yuan A, Yu CJ, Lin SB, Liou GY, Lee ML, Chen JJ, Hong TM, Yang SC, Su JL, Lee YC, Yang PC. Shih JY, et al. Clin Cancer Res. 2005 Nov 15;11(22):8070-8. doi: 10.1158/1078-0432.CCR-05-0687. Clin Cancer Res. 2005. PMID: 16299238

9

Survival outcome and predictors of gefitinib antitumor activity in East Asian chemonaive patients with advanced nonsmall cell lung cancer.

Yang CH, Shih JY, Chen KC, Yu CJ, Yang TY, Lin CP, Su WP, Gow CH, Hsu C, Chang GC, Yang PC. Yang CH, et al. Among authors: shih jy. Cancer. 2006 Oct 15;107(8):1873-82. doi: 10.1002/cncr.22220. Cancer. 2006. PMID: 16989002 Free article.

10

Predictive factors of gefitinib antitumor activity in East Asian advanced non-small cell lung cancer patients.

Chang GC, Tsai CM, Chen KC, Yu CJ, Shih JY, Yang TY, Lin CP, Hsu JY, Chiu CH, Perng RP, Yang PC, Yang CH. Chang GC, et al. Among authors: shih jy. J Thorac Oncol. 2006 Jul;1(6):520-5. J Thorac Oncol. 2006. PMID: 17409911 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

362 results

Search Page

Filters